跳至主要内容
临床试验/NCT02069288
NCT02069288撤回3 期

Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response, Gastric Mucosal Perfusion and Arterial Stiffness in Septic Shock

Rennes University Hospital1 个研究点 分布在 1 个国家开始时间: 2014年2月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
发起方
试验地点
1
主要终点
Norepinephrine-mean arterial pressure dose-response relationship

研究概览

简要总结

Septic shock (associated with relative adrenal insufficiency) is characterized by decreased arterial responsiveness to catecholamines. The association of hydrocortisone and fludrocortisone has demonstrated an improvement in survival in septic shock patients. If hydrocortisone has shown to increase vascular responsiveness, the role of fludrocortisone remains to be elucidated. The purpose of our study is to investigate the effect of a physiological dose of fludrocortisone alone on norepinephrine-mean arterial pressure dose-response relationship, gastric mucosal perfusion and arterial stiffness in patients with septic shock.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over than 18 years old
  • Septic shock
  • Haemodynamic stability (mean arterial pressure between 70 and 80 mmHg) for at least 1 hour, with a norepinephrine dose less than 0,5 µg/kg/min
  • Written informed consent

排除标准

  • Corticotherapy
  • Known allergy to Fludrocortisone
  • Esophageal or gastric disease
  • Pregnant woman
  • Inclusion in another clinical trial

研究组 & 干预措施

1

Experimental

Fludrocortisone

干预措施: Fludrocortisone (Drug)

2

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Norepinephrine-mean arterial pressure dose-response relationship

时间窗: 1.5 h after administration

次要结局

  • Plasma electrolytes, blood glucose, serum creatinine(Each hour during 3 h after administration)
  • Humeral diameter and distensibility(During 3 h after administration)
  • Central aortic pressures, Augmentation Index (Aix).(During 3 h after administration)
  • Plasma renin, aldosterone, norepinephrine, epinephrine, fludrocortisone, TNF alpha concentrations(Each hour during 3 h after administration)
  • Urinary electrolytes excretion(Each hour during 3 h after administration)
  • Arterial stiffness: Carotid-femoral Pulse Wave Velocity(During 3 h after administration)
  • Systolic and diastolic arterial pressures, heart rate, cardiac output, systemic vascular resistances(During 3 h after administration)
  • Gastric mucosal perfusion(During 3 h after administration)

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验